What the Xeljanz TV commercial - Needles: Sewing is about.
The Xeljanz TV Spot titled 'Needles: Sewing' is a commercial advertisement that aims to create awareness about the Xeljanz medication and its potential benefits in treating Rheumatoid Arthritis symptoms.
The commercial begins with a woman sitting at a desk, trying to sew with a needle and thread. As the camera zooms in, we see that the woman's hands are visibly shaky, and she is struggling to get the needle through the fabric. The implication is clear that this is a symptom of her Rheumatoid Arthritis and that the condition is affecting her daily life.
The scene then switches to the woman receiving a Xeljanz injection from her nurse. We see her go about her daily activities, completely free from the struggles she faced earlier in the commercial. She is shown confidently sewing, running, and playing with her dog, all without experiencing any pain or discomfort.
Throughout the commercial, the narrator highlights the potential benefits of Xeljanz in treating Rheumatoid Arthritis symptoms, such as reducing joint pain and swelling, and improving mobility. The ad also mentions that Xeljanz can be taken orally or injected, giving patients the flexibility to choose the method that works best for them.
Overall, the 'Needles: Sewing' TV Spot is a powerful visual representation of the impact that Rheumatoid Arthritis can have on a person's life, and how Xeljanz medication has the potential to help alleviate some of those symptoms and improve quality of life.
Xeljanz TV commercial - Needles: Sewing produced for
Xeljanz
was first shown on television on June 15, 2020.
Frequently Asked Questions about xeljanz tv spot, 'needles: sewing'
Xeljanz is an oral prescription medication approved to treat moderately to severely active rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. It also comes in an extended-release formulation, Xeljanz XR.
Generic Name: tofacitinib
Tofacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis-pcJIA). It helps to decrease pain/tenderness/swelling in the joints.
Serious side effects* of Xeljanz and Xeljanz XR may include:
- tears in your digestive tract.
- blood disorders.
- cardiovascular problems, such as heart attack or stroke.
- risk of serious infections†
- risk of blood clots†
- risk of cancer and immune system disorders†
- risk of death in certain people†
- allergic reaction.
Notes for Professionals: It is best to avoid taking Tofacitinib with grapefruit juice. The exposure to tofacitinib may be significantly increased in patients who regularly consume grapefruit or grapefruit juice, a strong CYP3A4 inhibitor.
On September 1, 2021, based on a completed FDA review of a large, randomized safety clinical trial, we have concluded that there is an increased risk of serious heart-related events such as heart attack or stroke, cancer, blood clots, and death with the arthritis and ulcerative colitis medicines Xeljanz and Xeljanz XR ...
No, Xeljanz and Xeljanz XR don't lead to weight gain or weight loss. But serious side effects of these drugs or your condition itself may cause unexplained weight loss. For example, weight loss can be seen with diarrhea, serious infection, and cancer. And these side effects can occur with Xeljanz and Xeljanz XR.
Is Xeljanz being recalled? No, at this time, in April 2022, Xeljanz has not been recalled even though the Xeljanz lawsuit list is growing by the week. However, the FDA has issued several warnings about the potential risks of taking the drug throughout the years.
Lymphomas and lung cancers were observed at a higher rate in patients treated at both doses of Xeljanz compared to those treated with TNF blockers. In particular, a higher rate of lung cancers was observed in current or past smokers treated with Xeljanz.
No, Xeljanz and Xeljanz XR don't lead to weight gain or weight loss. But serious side effects of these drugs or your condition itself may cause unexplained weight loss. For example, weight loss can be seen with diarrhea, serious infection, and cancer.
In patients treated with XELJANZ, malignancies were observed in clinical studies and the post-marketing setting including but not limited to: lymphomas, lung cancer, breast cancer, colorectal cancer, gastric cancer, melanoma, prostate cancer, pancreatic cancer, thyroid cancer and renal cell carcinoma (see 3 SERIOUS ...
Xeljanz Heart Attack Warning
An FDA_mandated post-marketing safety clinical trial identified this risk after the initial approval of Xeljanz. A 2023 study compared the risk of major adverse cardiovascular events between two medications, tofacitinib and tumor necrosis factor inhibitors.
Fatigue is a possible side effect of Xeljanz and Xeljanz XR. However, it's not known how often this side effect occurred in clinical studies. Fatigue may also be a symptom of more serious side effects of Xeljanz and Xeljanz XR, including: serious infections*
